Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/β‐catenin‐activated hepatocellular carcinoma. Issue 4 (11th January 2023)

• Record Type: Journal Article
• Authors: Matsuda, Kosuke; Kurebayashi, Yutaka; Masugi, Yohei; Yamazaki, Ken; Ueno, Akihisa; Tsujikawa, Hanako; Ojima, Hidenori; Kitago, Minoru; Itano, Osamu; Shinoda, Masahiro; Abe, Yuta; Sakamoto, Michiie
• Is Part Of: Hepatology research. Volume 53:Issue 4(2023)
• Page Start: 344
• Page End: 356
• Publication Date: 2023-01-11
• Subjects: angiogenesis -- fibroblast growth factor 2 -- T‐cell infiltration -- vessels encapsulating tumor clusters (VETC) -- WNT/β‐catenin signaling; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.13869
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract: Aim: WNT/β‐catenin‐activated hepatocellular carcinoma (W/B subclass HCC) is considered a molecularly homogeneous entity and has been linked to resistance to immunotherapy. However, recent studies have indicated possible heterogeneity in the immunovascular microenvironment in this subclass. We set out to test the hypothesis that specific immunovascular features might stratify W/B subclass HCCs into tumors having distinct aggressive natures. Methods: In this study, we analyzed 352 resected HCCs including 78 immunohistochemically defined W/B subclass HCCs. The density of tumor‐infiltrating CD3 + T cells and the area ratio of vessels encapsulating tumor clusters (VETC) were calculated on tissue specimens. The gene expressions of angiogenic factors were measured by quantitative reverse transcription–polymerase chain reaction. Disease‐free survival (DFS) was assessed using multivariable Cox regression analyses. Results: The T‐cell density of W/B subclass HCCs was regionally heterogenous within tumor tissues, and focally reduced T‐cell density was observed in areas with VETC. VETC‐positivity (defined as VETC area ratio greater than 1%) was inversely associated with T‐cell infiltration in both W/B subclass and non‐W/B subclass HCCs. Fibroblast growth factor 2 ( FGF2 ) gene expression was higher in W/B subclass than in non‐W/B subclass HCCs. The VETC‐positivity and low T‐cell density correlated with increased expression of FGF2 in W/B subclass HCCs. Additionally, VETC‐positive HCCs showed significantly shorter DFS in W/B subclass HCCs. Conclusions: In conclusion, the immune and vascular microenvironments are interrelated and are also correlated with clinicopathological heterogeneity in W/B subclass HCC. These results could inform clinical practice and translational research on the development of therapeutic stratification of HCCs.